- Today's Hot Chat Topics
- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Amphion Share News (AMP)
Share News for Amphion (AMP)
| Share Price: 2.375 | Bid: 2.25 | Ask: 2.50 | Change: -0.125 (-5.00%) |  | ||||||
| ||||||||||
Amphion raises further 1 mln pounds in 3rd round series C preferred financing
Fri, 23rd May 2008 08:09
LONDON (Thomson Financial) - Amphion Innovations Plc. said its partner company Myconostica Ltd
Amphion said this takes total funds raised in this series to 5.4 million pounds
The developer of medical and technology businesses said it now owns about 23 percent of Myconostica, which is now valued, fully diluted, at about 14 million pounds post money.
Myconostica is a University of Manchester spin-out company specialising in molecular diagnostic tests for infectious diseases, particularly respiratory fungal infections.
'With the close of this successful financing, we look forward to bringing Myconostica's innovative products to market in order to help the many patients who suffer from respiratory fungal infections each year,' Richard Morgan, Amphion's chief executive, said.
TFN.newsdesk@thomson.com
tsm/jag
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
LONDON (Thomson Financial) - Amphion Innovations Plc. said its partner company Myconostica Ltd
. has raised a further 1 million pounds from the UMIP Premier Fund at 40 pounds per share on the third close of the oversubscribed series C preferred financing.
Amphion said this takes total funds raised in this series to 5.4 million pounds
The developer of medical and technology businesses said it now owns about 23 percent of Myconostica, which is now valued, fully diluted, at about 14 million pounds post money.
Myconostica is a University of Manchester spin-out company specialising in molecular diagnostic tests for infectious diseases, particularly respiratory fungal infections.
'With the close of this successful financing, we look forward to bringing Myconostica's innovative products to market in order to help the many patients who suffer from respiratory fungal infections each year,' Richard Morgan, Amphion's chief executive, said.
TFN.newsdesk@thomson.com
tsm/jag
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
BRIEF-RESEARCH ALERT-Seymour Pierce starts Amphion Innovations with buy
Dec 16 (Reuters) - Amphion Innovations PLC: * Seymour pierce starts Amphion Innovations Plc with buy, price target 10P For[16 Dec '11]
BRIEF-Amphion Innovations reaches $17 mln patent settlements
LONDON, April 13 (Reuters) - Amphion Innovations Plc: * Won settlements from U.S. suits brought against multi-nationals for enforcem[13 Apr '11]
Amphion Innovations says partner company in IP licence deal with VISA
LONDON (Thomson Financial) - Amphion Innovations Plc. said its partner company DataTern Inc. has signed an intellectual property licence deal wi[17 Oct '08]
Amphion Innovations H1 net profit $10.02 mln vs $3.4 mln; EPS doubles to $0.08
LONDON (Thomson Financial) - Amphion Innovations Plc. reported a 194 percent increase in first-half net profit to $10.02 million from $3.4 milli[18 Aug '08]
Amphion Innovations expects further progress in H2, sees H1 NAV up over 15 pct
LONDON (Thomson Financial) - Amphion Innovations Plc. said it expects to see further progress in the second half of 2008 after it and and its pa[12 Jun '08]
Amphion sees revenues boost as DataTern agrees license of patents to Red Hat
LONDON (Thomson Financial) - Amphion Innovations Plc. said it will get an $800,000 boost to its revenues after partner company DataTern Inc. agr[10 Jun '08]
Amphion Innovations says partner co raises 1.6 million pounds at 8 pounds/shr
LONDON (Thomson Financial) - Amphion Innovations Plc. said its partner company Durham Scientific Crystals, Ltd has successfully raised 1.6 milli[27 May '08]
Amphion raises further 1 mln pounds in 3rd round series C preferred financing
LONDON (Thomson Financial) - Amphion Innovations Plc. said its partner company Myconostica Ltd. has raised a further 1 million pounds from the U[23 May '08]
